Datavault AI (NASDAQ: DVLT) reported Q3 2025 revenue of $2.904 million, up 148% YoY. It posted a GAAP net loss of $32.976 ...

These hedge fund managers beat the S&P 500 over the last three years, and they both bought Palantir and sold Rigetti ...

The Dow Jones index fell Thursday, following a record high in the previous session after news of the U.S. government shutdown ...

Roivant Sciences Ltd.'s innovative model and breakthrough autoimmune drug pipeline make it a strong buy. Click here to read ...

Markets extended gains in October as earnings strength, AI investment, and Fed easing supported sentiment, helping moat ...

Dillard's share repurchases have amplified shareholder value creation. Over the 39 weeks ending on Nov. 1, the retailer ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Tesla stock moved higher on Monday following a rough week as investment bank Stifel gets bullish. Analyst Stephen Gengaro upped his Tesla price target to $508 from $483 and maintained his Buy rating, ...

The Procter & Gamble Company (NYSE:PG) is one of the stocks Jim Cramer recently put under a microscope. Cramer highlighted ...

Michael Hartnett, Chief Investment Strategist at BofA Merrill Lynch Global Research, sees stocks maintaining their momentum ...

This paper represents the first attempt to examine investor behaviour for green stocks through the lens of return co-movement ...

Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...